Wednesday, June 10, 2026

pharma Β· Major Depressive Disorder Β· Primary Erythromelalgia Β· XENE

Xenon Pharmaceuticals

Xenon Pharmaceuticals clinical programs β€” 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

3650 Gilmore Way, Burnaby, BC V5G 4W8, CA HQ
397 Employees
Public company Type
XENE Β· NYSE Ticker
Company details
Status
Public
HQ
3650 Gilmore Way, Burnaby, BC V5G 4W8, CA
Employees
397
Programs
22
Drugs
2
Patents
106
Intelligence Β· Clinical Programs

Xenon Pharmaceuticals projects

5 ClinicalTrials.gov programs sponsored by Xenon Pharmaceuticals.

Xenon Pharmaceuticals has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 14C-XEN1101

    Xenon Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  2. XEN901

    Xenon Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  3. XPF-001

    Xenon Pharmaceuticals

    Healthy Human Volunteers

    phase 1 small molecule completed

    1 trial
  4. XPF-008

    Xenon Pharmaceuticals

    Healthy Male Volunteers

    phase 1 small molecule completed

    1 trial
  5. XPF-008

    Xenon Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Xenon Pharmaceuticals have?

5 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.